companydata.dkFORWARD PHARMA A/S: Financial statements 2014
CVR: 28865880
FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK -13,662,000. Equity amounted to DKK 238,017,000. The solvency ratio was 99%.
- Profit/Loss
- -13,662,000 kr.
- Equity
- 238,017,000 kr.
- Total Assets
- 240,310,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | - | -13.7 mio. | 238 mio. | - |
| 2012 | - | -11 mio. | 22.4 mio. | 50.4 mio. | - |
Keep an eye on FORWARD PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of FORWARD PHARMA A/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of FORWARD PHARMA A/S.
As of August 13, 2014, Johannes Gerardus Joseph van de Winkel has joined the board of directors of FORWARD PHARMA A/S.
As of August 5, 2014, Joel David Sendek is registered as økonomidirektør of FORWARD PHARMA A/S.
As of August 5, 2014, Joel David Sendek is registered as økonomidirektør of FORWARD PHARMA A/S.
As of August 5, 2014, Joel David Sendek has stepped down as økonomidirektør of FORWARD PHARMA A/S.
FORWARD PHARMA A/S has published its annual report for 2013.
About FORWARD PHARMA A/S
FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005 and dissolved in 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees. In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity amounted to DKK 488,330,233.